Tisagenlecleucel ni iki: Ibyo ikoreshwa, urugero rwo gufata, ingaruka ziterwa n'ibindi

Tisagenlecleucel ni uburyo bushya bwo kuvura kanseri bukoresha uturemangingo twawe twikingira kugira ngo turwanye kanseri zimwe na zimwe zo mu maraso. Ubu buryo bushya bwo kuvura, buzwi kandi nka CAR-T cell therapy, bufata uturemangingo twawe twa T (ubwoko bw'uturemangingo twera tw'amaraso), tukahindurwa muri laboratwari kugira ngo tumenye neza kandi turwanye uturemangingo twa kanseri, hanyuma tukongera kubashyira mu mubiri wawe.

Ubu buvuzi bugize intambwe ikomeye mu kwita ku kanseri ku buryo bwihariye. Bitandukanye na za chimiothérapie zisanzwe zikora ku turemangingo twose twihuta, tisagenlecleucel yibanda by'umwihariko ku turemangingo twa kanseri mu gihe ireka uturemangingo twiza tutagize icyo tubaho.

Tisagenlecleucel ikoreshwa mu kuvura iki?

Tisagenlecleucel ivura ubwoko bwihariye bwa kanseri zo mu maraso iyo izindi nshuti zitagize icyo zikora cyangwa iyo kanseri yagarutse. Muganga wawe akunda gutekereza kuri ubu buvuzi iyo umaze kugerageza nibura ubundi buryo bubiri bwo kuvura ariko ntibigire icyo bigeraho.

Uyu muti wemerewe kuvura kanseri ya lymphoblastic leukemia (ALL) mu bana n'urubyiruko rugeze ku myaka 25. ALL ni kanseri ikura vuba cyane ikibasira uturemangingo twera tw'amaraso, bigatuma umubiri wawe ugorwa no kurwanya indwara no kugenzura amaraso ava.

Ikoreshwa kandi mu bwoko bumwe na bumwe bwa lymphoma nini ya B-cell mu bantu bakuru. Ibi birimo diffuse large B-cell lymphoma na izindi lymphoma zifitanye isano zagarutse nyuma yo kuvurwa cyangwa zitagize icyo zikora ku buvuzi bwa mbere.

Tisagenlecleucel ikora ite?

Ubu buvuzi bukora buhindura urwego rwawe rwikingira mu mbaraga zikomeye zo kurwanya kanseri. Ubu buryo butangira iyo abaganga bakusanyije uturemangingo twawe twa T binyuze mu buryo busa no gutanga amaraso.

Muri laboratwari, abahanga bahindura utu turemangingo bongeramo ikintu cyihariye cyitwa chimeric antigen receptor (CAR). Uyu muti ukora nk'uburyo bwa GPS, bufasha uturemangingo twawe twa T gushaka no gufata proteyine yihariye iboneka ku turemangingo twa kanseri yitwa CD19.

Iyo uturemangingo twahinduriwe dusubijwe mu mubiri wawe, birororoka maze bigahinduka ibikoresho byiza byo kumenya no kurimbura uturemangingo twa kanseri. Bitekereze nk'uko uha umubiri wawe ubudahangarwa imyitozo idasanzwe n'ibikoresho byo kurwanya kanseri neza.

Ibi bifatwa nk'uburyo bukomeye kandi buhanitse bwo kuvura. Bitandukanye na chimiothérapie isanzwe, tisagenlecleucel ituma habaho igisubizo cy'ubudahangarwa kizima kandi gikomeza, gishobora gukomeza gukora mu mubiri wawe mu mezi cyangwa imyaka.

Nkwiriye Gufata Nte Tisagenlecleucel?

Tisagenlecleucel itangwa nk'urushinge rumwe rwo mu maraso mu kigo kivura cyihariye. Ntushobora gufata uyu muti uri mu rugo, kandi bisaba gutegurwa no gukurikiranwa neza n'ikipe y'abaganga babihuguriwe.

Mbere yo guhabwa ubuvuzi, uzanyura mu nzira yitwa leukapheresis kugira ngo bakusanye uturemangingo twawe twa T. Ibi bikunze gufata amasaha 3-6 kandi bikubiyemo kuvana amaraso mu kaboko kamwe, agakorwaho mu mashini itandukanya uturemangingo twa T, hanyuma agasubizwa mu kaboko kawe kundi.

Mugihe uturemangingo twawe turimo guhindurirwa muri laboratoire (bifata hafi ibyumweru 3-4), ushobora guhabwa chimiothérapie yo gufasha kugenzura kanseri yawe. Ikipe yawe y'abaganga izatanga amabwiriza yihariye yerekeye kurya, kunywa, n'imiti iyo ari yo yose yo kwirinda muri iki gihe.

Iminsi mike mbere yo guterwa urushinge, uzahabwa chimiothérapie yo gukuraho imisemburo kugira ngo utegure umubiri wawe. Ibi bifasha gushyiraho umwanya wo gutuma uturemangingo twahinduriwe dukura kandi dukora neza.

Guterwa urushinge rwa tisagenlecleucel bifata iminota 30-60. Uzagenzurwa neza mu bitaro byibura iminsi 10 nyuma yo guterwa urushinge, kuko iki gihe niho ingaruka zikomeye zishobora kubaho cyane.

Mbwiriza Gufata Tisagenlecleucel Igihe Kingana Gite?

Tisagenlecleucel itangwa nk'ubuvuzi bumwe, ntabwo ari umuti ukomeza gufata kenshi. Iyo uturemangingo twahinduriwe dushyizwe mu mubiri wawe, bigenewe gukomeza gukora igihe kirekire.

Uturembe twahinduwe twa T dushobora kuguma dukora mu mubiri wawe mu mezi cyangwa imyaka, bitanga uburinzi burambye ku turemangingo twa kanseri. Abarwayi bamwe bamaze imyaka myinshi barwaye kanseri ariko ntigaruka nyuma yo guhabwa ubu buvuzi bumwe.

Ariko, itsinda ryawe ry’abaganga rizakurikirana neza binyuze mu biganiro bisanzwe byo gukurikirana no gupima amaraso. Ibi bizafasha kumenya niba ubu buvuzi bukora neza no kureba niba hari ingaruka zatewe n’ubuvuzi cyangwa ibimenyetso bya kanseri bigaruka.

Ni izihe ngaruka ziterwa na Tisagenlecleucel?

Nubwo tisagenlecleucel ishobora kugira akamaro kanini, ishobora gutera ingaruka zikomeye zisaba ubufasha bwihuse bw’abaganga. Kubisobanukirwa bifasha wowe n’itsinda ryawe ry’abaganga gusubiza vuba niba bibayeho.

Ingaruka zikunze kugaragara kandi zikomeye ziterwa nuko uturemangingo twawe twahinduwe tw’ubudahangarwa tuba dukora cyane mu kurwanya kanseri. Ibi rimwe na rimwe bishobora gutera igisubizo gikabije cy’ubudahangarwa mu mubiri wawe wose.

Syndrome yo kurekura cytokine (CRS) ni ingaruka ikomeye cyane yo kwitondera. Ibi bibaho iyo uturemangingo twawe twa T dukora dushyira mu bice binini by’ibintu bitera umubiri kubyimba byitwa cytokines. Ibimenyetso bya mbere birimo:

• Urubore n'ubukonje
• Kugorwa no guhumeka cyangwa guhumeka bigufi
• Umutima utera vuba
• Kuribwa umutwe cyangwa kumva ureremba
• Kuribwa umutwe no kuribwa imitsi
• Isesemi no kuruka

CRS ishobora kuva ku gito kugeza ku kibazo giteye ubuzima bw’uburwayi, niyo mpamvu uzakurikiranwa hafi mu bitaro. Itsinda ryawe ry’abaganga rifite imiti n’ubuvuzi byihariye bwo guhangana n’iki kibazo neza.

Ingaruka z’imitsi nazo zirashobora kubaho, zigira ingaruka ku bwonko bwawe n’imitsi. Izi zirimo:

• Kuvurungana cyangwa kugorwa no kwibanda
• Kugorwa no kuvuga cyangwa kubona amagambo
• Kunyeganyega cyangwa guhinda umushyitsi
• Kugira ibibazo byo gufatwa (mu bihe bidasanzwe)
• Impinduka mu myandikire
• Kugorwa no gusinzira

Ingaruka nyinshi zo mu bwonko ziba iz'igihe gito kandi zikavaho nyuma y'ibyumweru bike, nubwo zimwe zishobora gutwara igihe kirekire kugira ngo zishire burundu.

Izindi ngaruka ushobora guhura nazo zirimo:

• Umubare muto w'uturemangingo tw'amaraso, bikongera ibyago byo kwandura indwara
• Umunaniro n'intege nke
• Kugabanya ubushake bwo kurya
• Ukubyimba mu maso, mu ntoki, cyangwa mu birenge
• Umubare muto w'amaraso
• Umutima utangira gukora nabi

Ingaruka zirambye zirimo umubiri udakora neza, bigatuma wibasirwa n'indwara. Muganga wawe azaganira nawe ku ngengabihe yo gukingira no gukumira indwara.

Ingorane zitabaho ariko zikomeye zirimo indwara zikomeye, kanseri ya kabiri, cyangwa umubare muto w'uturemangingo tw'amaraso. Itsinda ryawe ry'abaganga rizakurikirana neza ibi bishoboka mugihe cyo kugukurikirana.

Ninde utagomba gufata Tisagenlecleucel?

Tisagenlecleucel ntabwo ikwiriye kuri buri wese, kandi itsinda ryawe ry'abaganga rizagenzura neza niba uri umukandida mwiza kuri ubu buvuzi. Ibintu byinshi bishobora gutuma ubu buvuzi butakwiriye cyangwa buteye akaga cyane.

Ntabwo ushobora kwemererwa niba ufite indwara ikora kandi itagenzurwa. Umubiri wawe ugomba kuba umeze neza kugira ngo ukemure uburyo bukomeye bwo kwirinda indwara buterwa na tisagenlecleucel.

Ibibazo bikomeye by'umutima, ibihaha, umwijima, cyangwa impyiko bishobora gutuma uba ufite ibyago byinshi byo guhabwa ubu buvuzi. Ingaruka zishobora gushyira igitutu cyinshi kuri izi ngingo, bityo zigomba gukora neza bihagije kugira ngo zikemure ubu buvuzi.

Niba ufite indwara zimwe na zimwe ziterwa n'umubiri, ubu buvuzi ntibushobora gukwiriye. Ubu buvuzi bushobora gushimangira indwara ziterwa n'umubiri binyuze mu kongera gukora kw'umubiri wawe.

Ibikorwa bikomeye byabayeho mbere byerekeye ubuvuzi busa cyangwa ibice bimwe na bimwe by'ubuvuzi birashobora kandi kugukuraho kwakira tisagenlecleucel.

Muganga wawe azanatekereza ku buzima bwawe muri rusange, imyaka yawe, n'uburyo ushobora kwihanganira gukurikiranwa cyane n'ingaruka zishobora kubaho. Icyemezo kigizwe no gupima inyungu zishoboka n'ibibazo by'ubuzima bwawe bwihariye.

Izina ry'ubwoko bwa Tisagenlecleucel

Tisagenlecleucel icururizwa ku izina ry'ubwoko rya Kymriah. Iri zina ry'ubwoko rikoreshwa ku isi hose, bigatuma byorohereza abarwayi n'abaganga kumenya ubuvuzi bwihariye bwa CAR-T cell therapy.

Kymriah ikorwa na Novartis, isosiyete ikora imiti yateje imbere ubuvuzi butangaje. Iyo wumvise izina iryo ari ryo ryose - tisagenlecleucel cyangwa Kymriah - bivuga umuti umwe.

Itsinda ryawe ry'abaganga rishobora gukoresha ayo mazina yombi mu buryo busimburana, bityo ntugatangazwe niba wumva amagambo atandukanye avuga ku buvuzi bwawe.

Uburyo bwo gusimbuza Tisagenlecleucel

Ubuvuzi butandukanye bwa CAR-T cell therapy buraboneka, nubwo buri kimwe kigamije ubwoko bwihariye bwa kanseri n'abaturage barwaye. Ubu buryo bwo gusimbuza bukora kimwe na tisagenlecleucel ariko bushobora kugira ubundi buryo bwo kwemezwa cyangwa ingaruka zinyuranye.

Axicabtagene ciloleucel (Yescarta) ni ubundi buvuzi bwa CAR-T bwemerejwe lymphoma zimwe na zimwe mu bantu bakuru. Iyo kandi igamije CD19 ariko ikorwa mu buryo butandukanye kandi ishobora gukwira abaturage barwaye batandukanye.

Brexucabtagene autoleucel (Tecartus) yemerejwe ubwoko bumwe na bumwe bwa lymphoma na leukemia. Ubu buvuzi bugamije poroteyine imwe ya CD19 ariko bufite uburyo butandukanye bwo gukora.

Lisocabtagene maraleucel (Breyanzi) ni ubundi buryo bwo gufata lymphoma zimwe na zimwe, zagenewe gutera ingaruka nke zikomeye mugihe zikomeza gukora neza.

Uburyo bwo kuvura gakondo buracyashobora gutekerezwa bitewe n'ubuzima bwawe bwihariye. Ibi birimo imiti gakondo ya kanseri, imirasire, cyangwa kwimura selile ziva mu giti.

Umuhanga wawe mu by'indwara z'umwijima azagufasha kumenya uburyo bwiza bukwiriye ubwoko bwa kanseri yawe, ubuzima bwawe muri rusange, n'amateka y'imivuzi.

Ese Tisagenlecleucel iruta izindi terapiya za CAR-T?

Kugeragereza terapiya za CAR-T ntibyoroshye kuko buri imwe yageragejwe mu bantu batandukanye n'ubwoko bwa kanseri butandukanye. Ikintu cy'ingenzi ni ukubona imivuzi ikwiriye imiterere yawe.

Tisagenlecleucel yagaragaje ibisubizo byiza ku bana n'abantu bakuru bakiri bato bafite ALL, aho abarwayi benshi bageze ku gukira rwose. Amakuru y'igihe kirekire akomeza kugaragaza ibisubizo byiza kuri aba bantu.

Ku bantu bakuru bafite lymphoma, terapiya zitandukanye za CAR-T zishobora gukwira bitewe n'ubwoko bwa lymphoma n'amateka yawe y'ubuvuzi. Zimwe muri terapiya zishobora kugira ingaruka zitandukanye cyangwa igihe cyo gukora.

Uburyo bwiza buterwa n'ibintu nk'ubwoko bwa kanseri yawe, imivuzi yabanje, ubuzima bwawe muri rusange, n'uko imivuzi iboneka mu kigo cy'imivuzi yawe. Itsinda ryawe ry'abaganga rizaganira kuri ibi byose mugihe bagusaba uburyo bukwiye.

Aho kwibanda ku cyiza, ni ngombwa kumenya ko kugira uburyo bwinshi bwa CAR-T biha muganga wawe umwanya wo guhitamo imivuzi ikwiriye imiterere yawe yihariye.

Ibikunze Kubazwa Kuri Tisagenlecleucel

Ese Tisagenlecleucel irakwiriye abantu bafite ibibazo by'umutima?

Tisagenlecleucel ishobora kugira ingaruka ku mutima wawe, bityo kugira ibibazo by'umutima bisaba isuzuma ryitondewe. Imivuzi ishobora gutera impinduka mu mitsi y'amaraso, umutima, no gushyira igitutu gikomeye ku mikorere y'umubiri wawe.

Itsinda ryawe ry'abaganga rizasuzuma neza imikorere y'umutima wawe mbere yo kuvurwa binyuze mu bizami nk'ibipimo by'umutima cyangwa EKGs. Bazagereranya inyungu zishoboka n'ibibazo by'umutima kubera imiterere yawe.

Niba ufite ibibazo byoroheje by'umutima, ushobora kuba ukwiriye kwitabwaho cyane. Ariko, guhagarara k'umutima cyangwa gutera umutima vuba aha, bikunze gutuma ubu buvuzi butagira umutekano.

Nkwiriye gukora iki niba mbonye Tisagenlecleucel nyinshi ku buryo butunguranye?

Kurenza urugero rwa Tisagenlecleucel ntibishoboka mu buryo busanzwe kuko bitangwa nk'urugero rumwe, rwavuzwe neza n'abaganga bafite ubumenyi. Umubare ubonye ugenwa by'umwihariko hashingiwe ku gipimo cy'umubiri wawe n'umubare w'uturemangingo.

Niba ufite impungenge ku buvuzi bwawe cyangwa ufite ibimenyetso bitunguranye, hamagara ikipe yawe y'abaganga ako kanya. Barashobora gusuzuma niba ibimenyetso byawe bifitanye isano n'ingaruka zisanzwe z'ubuvuzi cyangwa ikintu gisaba ubufasha.

Ikipe y'abaganga ikurikiza amabwiriza akomeye kugira ngo yemeze ko ubona urugero rukwiye, bituma amakosa yo gutanga imiti adakunze kubaho.

Nkwiriye gukora iki niba nsubije urugero rwa Tisagenlecleucel?

Kuva Tisagenlecleucel itangwa nk'urugero rumwe, ntushobora rwose “kurengera” urugero nk'uko byagenda ku miti ya buri munsi. Ariko, niba urugero rwawe rwatanzwe rutinze cyangwa rugasubikwa, guma mu mibanire ya hafi n'ikipe yawe y'abaganga.

Gutinda kuvura birashobora kubaho kubera impamvu zitandukanye, nk'ibibazo byo gukora, indwara, cyangwa impinduka mu buzima bwawe. Ikipe yawe y'abaganga izakora kugira ngo itegure ubundi buvuzi vuba na bwangu uko byemewe.

Mugihe cyo gutinda, urashobora guhabwa ubuvuzi bwo gufasha kugenzura kanseri yawe kugeza igihe urugero rwa Tisagenlecleucel rutangwa.

Nshobora guhagarika ryari gufata Tisagenlecleucel?

Nti “uhagarika gufata” Tisagenlecleucel kuko ni ubuvuzi bumwe, ntabwo ari umuti ukomeza. Iyo uturemangingo twahinduwe twashyizwe mu mubiri wawe, bakomeza gukora bonyine.

Ibyo bishobora kumara amezi cyangwa imyaka, kandi abarwayi bamwe baguma mu gihe cyo gukira mu gihe kirekire nyuma yo kuvurwa rimwe. Itsinda ryawe ry’abaganga rizagukurikiranira hafi kugira ngo bamenye uko imiti ikora neza.

Niba kanseri yawe yagaruka cyangwa imiti itakora nk'uko byari byitezwe, muganga wawe azaganira nawe ku zindi nzira zo kuvurwa.

Nshobora guhabwa inkingo nyuma yo kuvurwa na Tisagenlecleucel?

Igihe cyo gukingirwa kwawe kigomba gucungwa neza nyuma yo kuvurwa na tisagenlecleucel. Ubuvuzi bushobora kugira ingaruka ku bushobozi bw’umubiri bwo kwirinda indwara bwo gusubiza ibikingira no kurwanya indwara.

Inkingo zikoreshwa zikunze kwirindwa nyuma yo kuvurwa na CAR-T kuko umubiri wawe ushobora kuba utameze neza. Itsinda ryawe ry’abaganga rizatanga amabwiriza yihariye yerekeye inkingo zifite umutekano n'igihe zizahabwa.

Abaganga benshi basaba gutegereza byibuze amezi menshi nyuma yo kuvurwa mbere yo guhabwa inkingo zimwe na zimwe, kandi bamwe bashobora gusaba gukoresha ibizamini by'ubudahangarwa mbere. Buri gihe jya inama n'itsinda ryawe ry’abaganga mbere yo guhabwa urukingo urwo arirwo rwose.